Paul Tudor Jones's TECH Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 242.0K shares of Bio-Techne Corporation (TECH) worth $13.46 M, representing 0.02% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in TECH, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2025, adding 223.8K shares. Largest reduction occurred in Q1 2024, reducing 146.1K shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Bio-Techne Corporation (TECH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Techne Corporation (TECH) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2014 | +28,800 | New Buy | 28,800 | $23.40 |
| Q4 2014 | -6,400 | Reduce 22.22% | 22,400 | $23.08 |
| Q1 2015 | -6,000 | Reduce 26.79% | 16,400 | $25.06 |
| Q2 2015 | -16,400 | Sold Out | 16,400 | $0.00 |
| Q1 2016 | +14,000 | New Buy | 14,000 | $23.64 |
| Q2 2016 | +16,800 | Add 120.00% | 30,800 | $28.18 |
| Q3 2016 | -30,800 | Sold Out | 30,800 | $0.00 |
| Q2 2019 | +25,612 | New Buy | 25,612 | $52.12 |
| Q3 2019 | -25,612 | Sold Out | 25,612 | $0.00 |
| Q4 2019 | +7,396 | New Buy | 7,396 | $54.89 |
| Q1 2020 | +13,516 | Add 182.75% | 20,912 | $47.39 |
| Q2 2020 | -20,912 | Sold Out | 20,912 | $0.00 |
| Q3 2020 | +24,184 | New Buy | 24,184 | $61.94 |
| Q4 2020 | -9,044 | Reduce 37.40% | 15,140 | $79.39 |
| Q1 2021 | -11,956 | Reduce 78.97% | 3,184 | $95.48 |
| Q2 2021 | +10,084 | Add 316.71% | 13,268 | $112.60 |
| Q3 2021 | -13,268 | Sold Out | 13,268 | $0.00 |
| Q2 2022 | +32,732 | New Buy | 32,732 | $86.67 |
| Q3 2022 | +45,408 | Add 138.73% | 78,140 | $71.00 |
| Q4 2022 | +548 | Add 0.70% | 78,688 | $0.08 |
| Q1 2023 | +85,574 | Add 108.75% | 164,262 | $0.07 |
| Q2 2023 | -164,262 | Sold Out | 164,262 | $0.00 |
| Q1 2024 | +18,183 | New Buy | 18,183 | $70.39 |
| Q2 2024 | -18,183 | Sold Out | 18,183 | $0.00 |
| Q3 2025 | +242,016 | New Buy | 242,016 | $55.63 |
Paul Tudor Jones's Bio-Techne Corporation Investment FAQs
Paul Tudor Jones first purchased Bio-Techne Corporation (TECH) in Q3 2014, acquiring 28,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Bio-Techne Corporation (TECH) for 45 quarters since Q3 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to Bio-Techne Corporation (TECH) was in Q3 2025, adding 242,016 shares worth $13.46 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 242,016 shares of Bio-Techne Corporation (TECH), valued at approximately $13.46 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bio-Techne Corporation (TECH) represents approximately 0.02% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in Bio-Techne Corporation (TECH) was 242,016 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.